Latest Breaking News On - Rebecca moninghoff pixabay - Page 1 : comparemela.com

American Journal of Psychiatry, is the first randomized, controlled trial of repeated ketamine administration for chronic PTSD and suggests this may be a promising treatment for PTSD patients. “Our findings provide insight into the treatment efficacy of repeated ketamine administration for PTSD, an important next step in our quest to develop novel pharmacologic interventions for this chronic and disabling disorder, as a large number of individuals are not sufficiently helped by currently available treatments,” said Adriana Feder, MD, Associate Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and lead author of the study. “The data suggests repeated IV ketamine is a promising treatment for people who suffer from PTSD and provides evidentiary support to warrant future studies to determine how we can maintain this rapid and robust response over time.”

United statesDenniss charneyRebecca moninghoff pixabayAdriana federIcahn school of medicine at mount sinaiDrug administrationPhoto creditRebecca moninghoffNew york cityIcahn schoolAmerican journalAssociate professorMount sinaiJoel ehrenkranz deanAcademic affairsMount sinai health